| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +10K | 100% | $1.25 | +$12.5K |
| Sells | 0 | ||||
| Net | +1 | +10K | 100% | +$12.5K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jeremy M. Sclar | 10%+ Owner | $10.6M | Jul 31, 2024 | ||
| Michael S. Gordon | 10%+ Owner | $2.65M | Jul 31, 2024 | ||
| Title 19 Promis | 10%+ Owner | $2.59M | Jul 31, 2024 | ||
| Eugene Williams | Director | $742K | Dec 16, 2022 | ||
| Neil Cashman | Chief Scientific Officer, Director | $533K | Oct 26, 2023 | ||
| William W. Wyman | Director | $292K | Jul 7, 2022 | ||
| Gail M. Farfel | Chief Executive Officer, Director | $256K | Aug 23, 2023 | ||
| Patrick Kirwin | Director | $124K | +$12.5K | +11.2% | Aug 14, 2024 |
| Max A. Milbury | Principal Accounting Officer | $69.6K | Oct 26, 2023 | ||
| Johanne Kaplan | Chief Development Officer | $29.3K | Oct 26, 2023 | ||
| Gavin T. Malenfant | Chief Operating Officer, Director | $12.3K | Oct 26, 2023 | ||
| Larry Douglas Altstiel | Chief Medical Officer | Oct 26, 2023 | |||
| Daniel E. Geffken | Chief Financial Officer | Oct 26, 2023 | |||
| Richard J. Gregory | Director | Jul 7, 2022 | |||
| Neil Warma | Chief Executive Officer | Jan 2, 2024 | |||
| Madge K. Shafmaster | Director | Jul 7, 2022 | |||
| Josh Mandel-Brehm | Director | Jul 7, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|